FDA Alerts
New Treatment for Diabetic Retinopathy
The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema.
FDA Approves Rx for Diabetic Retinopathy
The U.S. Food and Drug Administration today expanded the approved use for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME).
FDA Approves First Retinal Implant for Adults with Rare Genetic Eye Disease
The US Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
FDA Approves Jetrea For Eye Disease
The US Food and Drug Administration approved Jetrea (ocriplasmin), the first drug approved to treat an eye condition called symptomatic vitreomacular adhesion (VMA).
FDA Issues Second Warning to Physicians about Certain Compounded Drugs
FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G ( BBG ) during eye surgery since the FDA Warning to Physicians was posted on March 19, 2012.
FDA Issues Second Warning to Physicians about Certain Compounded Drugs
FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G ( BBG ) during eye surgery since the FDA Warning to Physicians was posted on March 19, 2012.
FDA Approves Eylea For Eye Disorder In Older People
The U.S. Food and Drug Administration today approved Eylea ( aflibercept ) to treat patients with wet ( neovascular ) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older.
FDA Alerts: Avastin
The U.S. Food and Drug Administration (FDA) is alerting health care professionals that repackaged intravitreal injections of Avastin ( bevacizumab ) have caused a cluster of serious eye infections in the Miami, Florida area.